India's second largest pharma company Dr Reddy's Laboratories reported a net profit of 1.7 billion rupees ($37 million) in the quarter to March, its fiscal fourth quarter, compared with a loss of 9.8 billion last year.
Vertex Pharmaceuticals Inc.’s experimental hepatitis C drug telaprevir could become ineffective as the virus strains turn resistant to the drug.
Registration of all clinical establishments made mandatory in India as part of its effort to bring in uniformity in the healthcare delivery sector.
Glenmark has entered into an exclusive licensing agreement with Par Pharmaceutical to market ezetimibe 10 mg tablets in US.
US FDA has warned Novartis against promoting the use of imatinib (Gleevec) in gastrointestinal stromal tumours (GIST) and chronic myelogenous leukemia (CML) in unapproved dosage strengths.
NOX-A12, an experimental stromal cell-derived factor-1 to treat various cancers developed by Noxxon, has successfully completed first-in-man studies, the company announced.